Patient Guides

Learn about direct-to-patient drug programs.

Free, unbiased guides to help you understand how manufacturer drug programs work, who qualifies, and how to find the lowest price for your medication.

EssentialsMarch 28, 20268 min read

What Are Direct-to-Patient Drug Programs?

Learn how direct-to-patient (DTP) programs work, who qualifies, and what to consider before enrolling. A complete guide for patients.

UninsuredMarch 28, 20269 min read

How to Get Prescription Drugs Without Insurance

Options for uninsured patients looking to access brand-name medications at lower prices through manufacturer direct-to-patient programs.

PolicyMarch 28, 202610 min read

Direct-to-Consumer Drug Programs: What Patients Need to Know

Understanding the difference between DTC and DTP programs, most-favored-nation pricing, and how these new models affect your prescription options.

SavingsMarch 28, 202610 min read

The Cheapest Way to Get Brand-Name Prescription Drugs

A comparison of every way to save on brand-name medications, from insurance formularies and copay cards to direct-to-patient programs.

Drug GuideMarch 28, 20268 min read

How to Get Ozempic Without Insurance in 2026

Ozempic costs $900–$1,100/mo at retail. NovoCare's direct-to-patient program offers it from $199/mo with no insurance required.

Drug GuideMarch 28, 20268 min read

How to Get Zepbound Without Insurance in 2026

Zepbound costs over $1,000/mo at retail. LillyDirect offers self-pay pricing from $299/mo — available to all patients including government-insured.

Drug GuideMarch 28, 20268 min read

How to Get Wegovy Without Insurance in 2026

Wegovy is available as an injection ($199–$349/mo) or tablet ($149–$299/mo) through NovoCare's direct-to-patient program. No insurance required.

Drug GuideMarch 29, 20267 min read

Cheapest Asthma & COPD Inhalers in 2026 — From $25.80 Cash

Brand-name inhalers from $25.80 without insurance. Compare Ventolin HFA, Spiriva, Striverdi, and Advair through DTP programs from GSK and Boehringer Ingelheim.

Industry WatchMarch 29, 20268 min read

Which Drug Makers Could Launch DTP Programs Next?

AbbVie (Humira, Skyrizi), Sanofi (Dupixent), and Merck (Keytruda) have not launched DTP programs yet. Here is what we know and what to watch for.

Ready to find your options?

Use our free tool to see which direct-to-patient programs match your condition and insurance status.

Find My Options